SBI² 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Toxicology and drug safety at SBI² 2026

Nov 2–4, 2026 Boston, MA ~300 attendees Website

6 organizations at SBI² 2026 present work in toxicology and drug safety: 2 universities and institutes, 2 drug developers and R&D companies and 2 vendors. Between them they bring 9 presentations to the program. Most represented: University of Michigan (1 on the program), Pixl Bio (1 on the program), Ananda Devices (1 on the program). As of Nov 2, 2026.

All 60 organizations at SBI² 2026 →

Format
Showing 1–6 of 6 organizations
OrganizationSBI² 2026 Attendance
Universities
Public research university whose medical school is home to a centre for drug repurposing.
Workshop
Mon Nov 2
1:00pm–3:00pm
AI Pair Programming
Using AI coding assistants to write, debug and check the analysis code for a real antiviral imaging assay.
Image analysis, data and AI
Session
Mon Nov 2
4:00pm–5:30pm
Colloquium: AI Today: The Good, The Bad and the Ugly
How pattern recognition, machine learning and language models help and mislead when applied to imaging assays.
Image analysis, data and AI · with IGGtec, University of Pittsburgh, Stanford University +4 more
Talk
Tue Nov 3
8:45am–9:15am
Ten Percent Yield: Mitigating Drug Discovery's Worst Adverse Event with Patient-Derived Liver Organoids
Whether imaging liver organoids grown from several patients' stem cells predicts drug-induced liver injury better than measuring cell death.
Organoids, organ-chips and complex cell models · Toxicology and drug safety
Biotech and other R&D companies
Company pairing human stem-cell-derived liver cells and organoids with AI analysis of cell images for drug discovery and safety.
Talk
Mon Nov 2
9:00am–12:00pm
A closed-loop phenomics engine for disease-relevant screening: modelling and pharmacological rescue of a fibrotic phenotype with Cell Painting
An automated two-microscope screening system that models lung scarring in cells and scores how compounds reverse it and what unwanted effects they cause.
Phenotypic screening and assays
Spotlight
Tue Nov 3
12:15pm–1:15pm
A closed-loop phenomics engine for disease-relevant screening: modelling and pharmacological rescue of a fibrotic phenotype with Cell Painting
An automated two-microscope screening system that models lung scarring in cells and scores how compounds reverse it and what unwanted effects they cause.
Spotlight hosted by Cephla
Phenotypic screening and assays
Reagents, labware and cell modelsLunch & Learn Sponsor
Developer of human organ-on-a-chip systems for neurons and neuromuscular junctions, used in preclinical drug discovery and neurotoxicity testing.
Spotlight
Tue Nov 3
12:15pm–1:15pm
High Content Analysis of NAM MPS Devices for Live Cell Analysis of 3D Human Neuromuscular Junctions
Testing human neuromuscular and neuron chips in a standard plate format, including an imaging method that detects muscle contraction without dyes.
Organoids, organ-chips and complex cell models · Toxicology and drug safety
Corteva Agriscience
Indianapolis, IN
Biotech and other R&D companies
Agricultural science company selling seeds and crop-protection products, with its own investigative toxicology research.
Talk
Mon Nov 2
9:00am–12:00pm
From Ideation to Application: A Case History of Establishing Phenotypic Profiling Assays for Chemical Hazard Screening
Building an imaging assay that profiles chemical hazards without animal testing, and how its results feed into chemical risk assessment.
Phenotypic screening and assays · Toxicology and drug safety
EMBL-EBI
Hinxton, UK
Research institutes and cancer centers
European Bioinformatics Institute, the part of EMBL on the Wellcome Genome Campus that runs public biological data resources.
Talk
Wed Nov 4
2:00pm–2:30pm
Multimodal Profiling for Mechanistic and Translational Prediction of Hepatotoxicity
Comparing Cell Painting, gene expression and protein profiling of the same compounds in liver cells as ways to predict liver toxicity.
Multi-omics and spatial profiling · Toxicology and drug safety
Emulate
Boston, MA
Reagents, labware and cell models
Maker of Organ-Chips and the instruments that run them, for testing how human tissue responds to drugs.
Talk
Tue Nov 3
11:00am–11:30am
A Real-Time Window into Human Biology: Advancing Organ-on-a-Chip Technology from Validation to Routine Use
How organ-on-a-chip systems recreate human tissue for imaging, and a new automated platform meant to make liver-injury testing routine.
Organoids, organ-chips and complex cell models · Toxicology and drug safety

Explore the full SBI² 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full SBI² 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in toxicology and drug safety

Tell us what you sell and we’ll find the people at organizations working on toxicology and drug safety most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SBI² 2026 by

Exhibit hall

Not affiliated with or endorsed by the Society of Biomolecular Imaging and Informatics. Submit a correction